Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Connected Device Detects Fluid Accumulation in Lungs

By HospiMedica International staff writers
Posted on 10 Dec 2018
A portable acoustic sensor enables early intervention in patients with congestive heart failure (CHF) by allowing them to check for excess lung fluids at home.

Developed by researchers at Nanyang Technological University (NTU; Singapore) and Tan Tock Seng Hospital (TTSH; Singapore), the prototype handheld medical device, which resembles a stethoscope, can identify excess fluid in the lungs in just 10 seconds by detecting audible crackles. Depending on the intensity, a crackle may sound like salt added to a hot pan, or like Velcro being torn apart. A smartphone app sends the sounds to a proprietary algorithm stored in the cloud, which than identifies if the patient has fluid accumulation in the lungs.

In a pilot study of the device that examined lung sounds recorded from CHF patients tested at TTSH, the researchers found that the device exhibited 92% accuracy in identifying CHF, comparable to the existing gold standard diagnosis methods, X-rays and computerized tomography (CT) scans. Following the two initial rounds of tests with audio samples collected from 86 patients, the researchers are now running a third round of tests on the device in order to further validate its sensitivity and specificity.

“Our smart medical device can be used by anyone, anywhere and any number of times, which will enable the possibility of early intervention of congestive heart failure,” said project leader Ser Wee, PhD, of the NTU. “The next wave of MedTech start-ups will see the massive proliferation of smart medical devices that rely on artificial intelligence and sensing technologies, such as the one we invented, and that will enable personalized self-assessment and screening of cardiopulmonary and other diseases.”

In CHF, a diseased heart ventricle (usually the left one) cannot pump out enough of the blood it receives from the lungs. This causes pressure to build up in the heart, backing up into the veins and capillaries of the lungs. The pressure build-up pushes fluid through the capillary walls and into the pulmonary air sacs. Currently, patients can only check for fluid accumulation by clinical auscultation, which is noticeably subjective, or through imaging modalities and serum biomarker tests, which are costly and take a longer time.

Related Links:
Nanyang Technological University
Tan Tock Seng Hospital


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Double Door Pharmacy Refrigerator
iPR256-GX
New
CPAP Machine
EcoStar Auto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.